Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes

Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes

Renin–angiotensin system (RAS) blockade by angiotensin-converting enzyme inhibitors (ACEis) or angiotensin-receptor blockers (ARBs) has been related to anemia in various situations. We aimed to investigate whether discontinuation of RAS inhibitors improves erythropoiesis in patients with lower-risk...

Full description

Bibliographic Details
Main Authors: George Pavlidis, Sotirios G. Papageorgiou, Efthimia Bazani, Anthi Bouchla, Eirini Glezou, Konstantinos Gkontopoulos, Thomas Thomopoulos, Vasiliki Pappa, Demetrios V. Vlahakos
Format: Article
Language:English
Published: SAGE Publishing 2021-01-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/2040620720958299

Internet

https://doi.org/10.1177/2040620720958299

Similar Items